Parkman Healthcare Partners LLC Grows Stock Holdings in CVS Health Corporation $CVS

Key Points

• Parkman Healthcare Partners LLC increased its stake in CVS Health Corporation by 176.0%, holding 496,736 shares valued at approximately $33.65 million, making it the firm’s second-largest investment.
• CVS Health reported a net margin of 1.17% and a quarterly revenue of $98.92 billion, exceeding analyst estimates, with earnings per share of $1.81.
• The company declared a **quarterly dividend** of $0.665, providing a yield of 3.6%, with a payout ratio of 74.30%.

Parkman Healthcare Partners LLC grew its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 176.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 496,736 shares of the pharmacy operator's stock after purchasing an additional 316,736 shares during the quarter. CVS Health makes up approximately 4.0% of Parkman Healthcare Partners LLC's holdings, making the stock its 2nd biggest holding. Parkman Healthcare Partners LLC's holdings in CVS Health were worth $33,654,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Cary Street Partners Financial LLC acquired a new stake in shares of CVS Health during the fourth quarter worth $647,000. Cetera Investment Advisers boosted its holdings in CVS Health by 2.1% during the fourth quarter. Cetera Investment Advisers now owns 318,779 shares of the pharmacy operator's stock worth $14,310,000 after buying an additional 6,524 shares during the last quarter. CoreCap Advisors LLC grew its position in shares of CVS Health by 18.6% during the 4th quarter. CoreCap Advisors LLC now owns 4,328 shares of the pharmacy operator's stock worth $194,000 after buying an additional 679 shares during the period. Deutsche Bank AG increased its stake in shares of CVS Health by 46.0% in the 4th quarter. Deutsche Bank AG now owns 4,379,753 shares of the pharmacy operator's stock valued at $196,607,000 after acquiring an additional 1,379,932 shares during the last quarter. Finally, Fairfax Financial Holdings Ltd. Can acquired a new stake in shares of CVS Health in the 4th quarter valued at approximately $121,742,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.22% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CVS shares. Baird R W upgraded shares of CVS Health from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 14th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $78.00 price objective on shares of CVS Health in a research report on Tuesday, August 26th. Robert W. Baird upgraded CVS Health from a "neutral" rating to an "outperform" rating and increased their target price for the stock from $71.00 to $82.00 in a report on Thursday, August 14th. Jefferies Financial Group boosted their price target on CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a report on Monday, June 30th. Finally, UBS Group upgraded CVS Health from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $67.00 to $79.00 in a report on Monday, August 18th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $77.89.

CVS Health Stock Performance

NYSE CVS traded up $2.18 on Wednesday, hitting $73.93. 10,665,643 shares of the stock were exchanged, compared to its average volume of 6,409,952. The company has a market capitalization of $93.76 billion, a PE ratio of 20.65, a P/E/G ratio of 0.79 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The business's fifty day moving average is $66.67 and its 200 day moving average is $66.09. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $74.53.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company's quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd were paid a $0.665 dividend. The ex-dividend date was Tuesday, July 22nd. This represents a $2.66 annualized dividend and a yield of 3.6%. CVS Health's dividend payout ratio is currently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.